The Psychedelic Spotlight reports
Some good news today for psychedelics advocates: A judge has granted a hearing for opposition of the U.S. Drug Enforcement Agency’s proposal to add five more hallucinogenic compounds in schedule I of the Controlled Substances Act.
The regulator announced intent in January to criminalize 4-Hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alphamethyltryptamine (5-MeO-AMT), N-Isopropyl-5-Methoxy-N-Methyltryptamine (5-MeO-MiPT), N,N-Diethyl-5-methoxytryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT); not just for possession, distribution, import, export or manufacturing, but even research, instructional activities and chemical analysis.
Administrative Law Judge Teresa A. Wallbaum issued an order today declaring a prehearing conference regarding this matter will be conducted by video conference on May 4 at 1 PM ET. In wake of receiving four different requests for a hearing from a mix of psychedelic industry professionals and researchers, Judge Wallbaum ordered that the government file a prehearing statement no later than March 28, and further ordered that each party requesting a hearing file prehearing statements no later than April 27.
dea-proposed-psychedelics-banA 28-page DEA report — authored in August of 2021, and based on Department of Health and Human Services reviews of these psychedelics from 2012 — states, “These five tryptamines have no known medical use in the United States and are not marketed internationally as approved drug products. They have all been reported as drugs of abuse in the U.S. by law enforcement authorities and identified in seizures.”
The document concludes that these five tryptamines meet requirements for schedule 1 classification because of the following three factors: The drug has a high potential for abuse, the drug has no currently accepted medical use in treatment in the United States, and there is a lack of accepted safety for use of the drug under medical supervision.
Read full report at
Judge Grants Hearing for Opposition to DEA Proposal to Criminalize 5 More Psychedelics
Also read
DEA Faces Challenge To Proposed Psychedelics Ban In Its Own Administrative Court
